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Abstract
Cholesteatoma is life-threatening disease due to its intracranial 
complications. Some of cholesteatoma cases we define as aggressive 
cholesteatoma. In this category we include children cholesteatoma, 
medially-invasive cholesteatoma and petrous apex cholesteatoma 
which does not originate in the petrous apex. Another special form 
of cholesteatoma is petrous bone cholesteatoma. Retrospective study 
of 176 cholesteatoma operations (38.85%) from 453 consecutive 
middle ear surgeries for 4 years and 4 months in Trakia Park 
Hospital Stara Zagora, Bulgaria were rewieved. The same surgeon 
performs 106 Primary Cholesteatoma Surgery, 49 Revision Surgery 
and 21 Second-Look Surgery. In this 176 cholesteatoma cases 
the cholesteatoma matrix involve the otic capsule, petrous apex 
or skull base in 5 patients, who are defined as medially-invasive 
cholesteatoma (2.84%). In this medially-invasive cholesteatoma 
patients surgical resection with canal wall down operation remains 
the best treatment option.
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Introduction
Cholesteatoma is a well-demarcated noncancerous 
cystic lesion derived from an abnormal growth of 
keratinizing squamous epithelium in the temporal 
bone, which is commonly characterized as wrong 
“skin in the wrong place” [1]. Cholesteatoma 
results from the enzymatic activity of the chole-
steatoma matrix. Its abnormal growth is locally 
invasive and capable of causing the destruction of 
structures in the middle ear. The cortical temporal 
bone and otic capsule unlike the cellular system 
of the mastoid process are difficult to resorb, but 
in rare cases, the destruction may be in the medi-
al direction deep into the temporal bone. When 
cholesteatoma matrix involve the otic capsule, 
petrous apex or skull base we call it medially-in-
vasive cholesteatoma [2]. The surgical strategy is 
based of cholesteatoma location seen at computed 
tomography and preoperative audiovestibular sta-
tus preserving the function of the facial nerve [3]. 
Apical and supralabyrinthine lesions can be treated 
by a middle fossa approach, infralabyrinthine and 
translabyrinthine locations can be exposed through 
a subtotal petrosectomy or a transotic route, and 
the retrolabyrinthine lesion can be approached via 
retrolabyrinthine route. Some of cholesteatoma 
cases we define as aggressive cholesteatoma. In 
this category we include children cholesteatoma, 
medially-invasive cholesteatoma and petrous apex 
cholesteatoma which does not originate in the 
petrous apex. Another special form of cholesteato-
ma is petrous bone cholesteatoma [4, 5]. Subtotal 
petrosectomy is defined as complete exenteration 
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of all pneumatic cell tracts of the temporal bone 
with or without removal of the otic capsule. [6, 7].
Material and methods
Retrospective study of 176 cholesteatoma opera-
tions (38.85%) from 453 consecutive middle ear 
surgeries for 4 years and 4 months in Trakia Park 
Hospital Stara Zagora, Bulgaria. The same sur-
geon performs 106 Primary Cholesteatoma Surgery 
(60.23%, n=176), 49 Revision Surgery (27.84%, 
n=176; previous operations in another hospital) 
and 21 Second-Look Surgery (11.73%, n=176). 
Sex and side distribution is: Male 88, Female 67; 
Left ear 78, Right ear 77. The Bellucci Classifi-
cationdistribution is: Gr. 1/5%; Gr. 2/21%; Gr. 
3/68%; Gr. 4/6%. 155 patients aged 4 to 76 years 
(mean age 35.8 years; SD 18.0 years) were surgi-
cally treatment and included for follow-up from 
24 to 60 months (mean 31.34 months; SD 13.10) 
between 01.06.2014 and 30.09.2018. 5 patients 
from them are defined as medially-invasive chole-
steatoma. This was manly young people (average 
age 26.8; SD 10.06), 4 male and 1 female, 3 right 
2 left side. All patients have Bellucci classifica-
tion Gr 3/4. The follow-up included surveillance 
with clinical examination and audiometry on 3, 
6, 12 months after surgery plus DWI-MRI on 18 
months after surgery; then once a year. MRI has 
been found to be of high sensitivity and specificity 
in diagnosing residual or reccurent cholesteatoma, 
especially diffusion-weighted (DW) imaging with 
turbo-spin echo (TSE) [8]. Second-look surgery is 
usually performed on 18 months after surgery, such 
as the indication for that must be placed of the end 
of previous operation
Fig. 1.1. Axial CT Scan from medially-
invasive congenital cholesteatoma on the 
right side.
Fig. 1.2. Axial CT Scan from medially-
invasive congenital cholesteatoma on the 
right side.
Results
In all patients surgical resection remains the best 
treatment option for this medially-invasive cho-
lesteatoma. Our surgical principles include: (I) 
Need to provide bony explosure aroud disease; (II) 
Special attention to the facial nerve, dura mater or 
carotid artery; (III) When CSF leak is a concern, 
a subtotal petrosectomy with closure of the ear 
is often necessary. The patients were assessed for 
postoperative audiologic and facial functions and 
for recurrence of cholesteatoma. One has persistent 
otorrhea (Case 1 / Fig. 1.1, Fig. 1.2); one has dizzi-
ness (Case 2 / Fig. 2.1, Fig. 2.2, Fig. 2.3) and one 
has intermittent facial paresis (Case 3 / Fig. 3.1, 
Fig. 3.2, Fig. 3.3, Fig. 3.4, Fig. 3.5)
Discussions
Cholesteatoma is life-threatening disease due to 
its intracranial complications. In the past the sur-
geon used open techniques to treat the infectious 
disease and to safe the life. In the XX century the 
surgeon used closed techniques with canal recon-
struction to preserve the hearing. Nowadays we 
used obliterations technique to eradicate the dis-
ease and to prevent the recurrence. Mastoid cavity 
obliteration could be done after certain removal of 
all epithelium from middle ear space. Following 
the matrix of cholesteatoma including complete 
cholesteatoma removal from anterior to posterior 
with preservation of malleus handle and m. tensor 
tympani tendon if it is possible. The drill should 
not touch the epithelium and should avoid spread-
ing of cholesteatoma particles. Before reconstruc-
tion inspection with 70° endoscopes is needed to 
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Fig. 2.1. Axial CT Scan from medially-
invasive cholesteatoma to the posterior 
semicircular canal on the right side.
Fig. 2.2. Axial CT Scan from medially-
invasive cholesteatoma to the posterior 
semicircular canal on the right side.
Fig. 3.4. Horizontal diameter on the 
lesion (D1=1.72 cm).
Fig. 2.3. Axial CT Scan from medially-
invasive cholesteatoma to the posterior 
semicircular canal on the right side.
Fig. 3.5. Vertical diameter on the 
lesion (D2=1.19 cm).
Fig. 3.1. Petrous apex cholesteatoma 
on the left side.
Fig. 3.2. Petrous apex cholesteatoma 
on the left side.
Fig. 3.3. DWI-MRI (diffusion-weighted 
imaging with turbo-spin echo) 18 
months after surgery display the 
residual cholesteatoma in petrous apex 
area on the left side.
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be sure, that all epitelium is removed. This oblit-
eration procedure is designed to prevent devel-
opment of postoperative retraction pockets by 
obliterating the mastoid cavity using bone paté or 
synthetic bone, covered with cartilage or connec-
tive tissue and resulting isolation the tympanum 
from the attic and mastoid.
The surgeon‘s experience is essential to the success 
of cholesteatoma surgery. The so-called “drill guy” 
is the professional, who builds in the temporal bone 
laboratory, and who is in fact a key person in reduc-
ing the cases with recurrence of cholesteatoma. In 
cases of medially-invasive cholesteatoma otologic 
surgeon (Middle ear; Ossiculoplasties; Mastoid-
ectomy) goes to temporal bone surgeon (Subtotal 
Petrosectomy; Petrous Apex Surgery) to get to 
lateral skull base surgeon or neurosurgeon (Subto-
tal Petrosectomy; Middle Fossa Surgery; Transot-
ic/Translabyrinthine route surgery; Infratemporal 
Fossa Approach Type A, B, C a modo Fish etc.).
Conclusion
Our experience shows that medially invasive 
choleateatoma are observed exclusively in patients 
with prolonged and resistant to treatment otorrhea. 
The CT scans of these patient shows well-devel-
oped mastoid pneumatization. The medially-inva-
sive cholesteatoma demonstrates an aggressive, 
endophytic growth pattern, invading into the otic 
capsule or through the perilabyrinthine air cells to 
the petrous apex. Surgical resection with canal wall 
down surgery remains the best treatment option 
for medially-invasive cholesteatoma. In some 
cases may be necessary transcochlear or skull-base 
approaches to eradicate the disease and the chole-
steatoma matrix may be adherent to facial nerve 
and membranous labyrinth. We must be having 
special attention when engaging the carotid artery 
or jugular bulb, such as in this cases infratemporal 
fossa approach is preferable
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